Leading-edge healthcare: Industrial Strategy Challenge Fund

An overview of government's programme to develop and manufacture new medicines, digital health products and medical technologies. What is the leading-edge healthcare challenge? The leading-edge healthcare challenge is part of the Industrial Strategy Challenge Fund . We are faced with the challenge of manufacturing many different types of medicines, and getting the right drugs and treatments to individual patients when they need them. Government will invest £181 million to speed up access to new medicines and drugs and improve healthcare. It will establish new facilities and support research and innovation projects that accelerate the development and manufacture of vital advanced therapies, medicines and vaccines. The fund is estimated to return £1 billion to the UK economy, support high-value, highly-skilled manufacturing and increase productivity. Innovate UK will deliver the challenge on behalf of UK Research and Innovation , with input from the Office for Life Sciences . Accelerating Innovative Medicines challenge The funding is in 4 areas: advanced therapies treatment centres medicines manufacturing projects viral vector production projects digital health technology catalyst

Deadline

—

Open date

18 Apr 2018

Funding

— – —

TRL

—

Eligible entities

—

Eligible countries

GB

Topics

Leading-edge healthcare: Industrial Strategy Challenge Fund